AJANTA PHARMA LTD. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
03 Aug 2022
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst/Institutional Investor Meeting with the Company.
Source:
BSE India